Literature DB >> 9590365

Serum creatine kinase activity is not a reliable marker for muscle damage in conditions associated with low extracellular glutathione concentration.

J J Gunst1, M R Langlois, J R Delanghe, M L De Buyzere, G G Leroux-Roels.   

Abstract

Creatine kinase (CK, EC 2.7.3.2) assays usually contain thiol-reducing compounds to restore the enzyme activity. In this study, we investigated the effect of endogenous extracellular glutathione on serum CK activity. We examined CK activity and glutathione concentrations in serum from 200 healthy subjects (107 males, 93 females) and 38 patients with multiple organ failure, muscle wasting, and low serum CK activity (<50 U/L) (24 males, 14 females). Muscle damage was further evaluated using serum myoglobin concentrations and aldolase activity. In the overall group, serum glutathione concentrations correlated with serum CK activity (r = 0.791) but not with myoglobin concentrations and aldolase activity. In patients with multiple organ failure, low serum CK activities were accompanied by extremely low serum glutathione concentrations (<0.5 ,micromol/L, P <0.001). Endogenous glutathione can be regarded as a CK-preserving agent during the lifetime of the enzyme in the circulation (22 h on average). Serum CK activity should be interpreted with caution in patients with liver disease and multiple organ failure. In these conditions, the loss of CK activity due to extracellular glutathione depletion cannot be restored by the presence of thiol-reducing compounds in the CK assays.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9590365

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  8 in total

1.  Serum agrin and talin are increased in major depression while agrin and creatine phosphokinase are associated with chronic fatigue and fibromyalgia symptoms in depression.

Authors:  Hussein Kadhem Al-Hakeim; Ameer Abdul Razzaq Al-Issa; Michael Maes
Journal:  Metab Brain Dis       Date:  2019-11-16       Impact factor: 3.584

2.  Changes in Insulin Sensitivity and Lipid Profile Markers Following Initial and Secondary Bouts of Multiple Eccentric Exercises.

Authors:  Trevor C Chen; Min-Jyue Huang; Leonardo C R Lima; Tai-Ying Chou; Hung-Hao Wang; Jui-Hung Tu; Shi-Che Lin; Kazunori Nosaka
Journal:  Front Physiol       Date:  2022-06-06       Impact factor: 4.755

3.  Tissue-Engineered Human Myobundle System as a Platform for Evaluation of Skeletal Muscle Injury Biomarkers.

Authors:  Alastair Khodabukus; Amulya Kaza; Jason Wang; Neel Prabhu; Richard Goldstein; Vishal S Vaidya; Nenad Bursac
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

4.  Imaging of zebrafish in vivo with second-harmonic generation reveals shortened sarcomeres associated with myopathy induced by statin.

Authors:  Shih-Hao Huang; Chung-Der Hsiao; Dar-Shong Lin; Cho-Yen Chow; Chia-Jen Chang; Ian Liau
Journal:  PLoS One       Date:  2011-09-23       Impact factor: 3.240

5.  Creatine supplementation enhances muscle force recovery after eccentrically-induced muscle damage in healthy individuals.

Authors:  Matthew B Cooke; Emma Rybalka; Andrew D Williams; Paul J Cribb; Alan Hayes
Journal:  J Int Soc Sports Nutr       Date:  2009-06-02       Impact factor: 5.150

6.  Muscle-Derived Proteins as Serum Biomarkers for Monitoring Disease Progression in Three Forms of Muscular Dystrophy.

Authors:  Peter M Burch; Oksana Pogoryelova; Richard Goldstein; Donald Bennett; Michela Guglieri; Volker Straub; Kate Bushby; Hanns Lochmüller; Carl Morris
Journal:  J Neuromuscul Dis       Date:  2015-09-02

Review 7.  A review of the evidence concerning hepatic glutathione depletion and susceptibility to hepatotoxicity after paracetamol overdose.

Authors:  Sarbjeet S Kalsi; Paul I Dargan; W Stephen Waring; David M Wood
Journal:  Open Access Emerg Med       Date:  2011-12-23

8.  Hemophagocytic Syndrome Complicated with Dermatomyositis Controlled Successfully with Infliximab and Conventional Therapies.

Authors:  Yoji Komiya; Tetsuya Saito; Fumitaka Mizoguchi; Hitoshi Kohsaka
Journal:  Intern Med       Date:  2017-12-01       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.